253 related articles for article (PubMed ID: 26528829)
21. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?
O'Leary ST; Suh CA; Marin M;
Vaccine; 2012 Nov; 30(48):6731-3. PubMed ID: 22975026
[TBL] [Abstract][Full Text] [Related]
22. Association of the use of MMRV in infants by pediatric infectious disease specialists with that of other affiliated providers.
Ackerson BK; Li BH; Sy LS; Cheetham TC; Jacobsen SJ
Vaccine; 2014 Apr; 32(16):1863-8. PubMed ID: 24508041
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
24. The evolution of vaccines for early childhood: the MMRV.
Ferrera G; Squeri R; Genovese C
Ann Ig; 2018; 30(4 Supple 1):33-37. PubMed ID: 30062378
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
26. Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Prymula R; Povey M; Brzostek J; Cabrnochova H; Chlibek R; Czajka H; Leviniene G; Man S; Neamtu M; Pazdiora P; Plesca D; Ruzkova R; Stefkovicova M; Usonis V; Verdanova D; Wysocki J; Casabona G; Habib MA
Vaccine; 2021 May; 39(19):2643-2651. PubMed ID: 33858718
[TBL] [Abstract][Full Text] [Related]
27. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Vesikari T; Karvonen A; Lindblad N; Korhonen T; Lommel P; Willems P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2010 Jun; 29(6):e47-56. PubMed ID: 20508478
[TBL] [Abstract][Full Text] [Related]
29. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.
Bauchau V; Van Holle L; Cohen C
Drug Saf; 2015 Nov; 38(11):1095-102. PubMed ID: 26251259
[TBL] [Abstract][Full Text] [Related]
30. Safety of measles, rubella and mumps vaccines in adults: a prospective cohort study.
Ami N; Eyal N; Asaf B; Chen A; Adi B; Drorit A; Neta P; Hajar D; Stav R; Eli S
J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34101817
[TBL] [Abstract][Full Text] [Related]
31. Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin.
Rüger G; Gabutti G; Rümke H; Rombo L; Bernaola E; Diez-Domingo J; Martinon-Torres F; Høgh B; Konstantopoulos A; Fiquet A; Thomas S; Eymin C; Baudin M
Pediatr Infect Dis J; 2012 Nov; 31(11):1166-72. PubMed ID: 22772170
[TBL] [Abstract][Full Text] [Related]
32. A combination vaccine against measles, mumps, rubella and varicella.
Knuf M; Faber J; Barth I; Habermehl P
Drugs Today (Barc); 2008 Apr; 44(4):279-92. PubMed ID: 18536786
[TBL] [Abstract][Full Text] [Related]
33. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.
;
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):258-60. PubMed ID: 18340332
[TBL] [Abstract][Full Text] [Related]
34. Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017.
Stefanizzi P; De Nitto S; Patano F; Bianchi FP; Ferorelli D; Stella P; Ancona D; Bavaro V; Tafuri S
Hum Vaccin Immunother; 2020 Aug; 16(8):1875-1883. PubMed ID: 32040350
[TBL] [Abstract][Full Text] [Related]
35. Analysis of safety data in children after receiving two doses of ProQuad® (MMRV).
Klopfer SO; Stek JE; Petrecz M; Reisinger KS; Black SB; Goveia MG; Nicholson O; Gardner JL; Grosso AD; Brown ML; Kuter BJ; Schödel FP
Vaccine; 2014 Dec; 32(52):7154-60. PubMed ID: 25219563
[TBL] [Abstract][Full Text] [Related]
36. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
Klein NP; Fireman B; Yih WK; Lewis E; Kulldorff M; Ray P; Baxter R; Hambidge S; Nordin J; Naleway A; Belongia EA; Lieu T; Baggs J; Weintraub E;
Pediatrics; 2010 Jul; 126(1):e1-8. PubMed ID: 20587679
[TBL] [Abstract][Full Text] [Related]
37. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella.
Streng A; Liese JG
Vaccine; 2014 Feb; 32(8):897-900. PubMed ID: 24412300
[TBL] [Abstract][Full Text] [Related]
38. Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety.
Ma SJ; Li X; Xiong YQ; Yao AL; Chen Q
Medicine (Baltimore); 2015 Nov; 94(44):e1721. PubMed ID: 26554769
[TBL] [Abstract][Full Text] [Related]
39. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
Sanftenberg L; Schrörs HJ; Schelling J
Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study.
Santos EMD; Noronha TG; Alves IS; Cruz RLS; Ferroco CLV; Brum RC; Oliveira PMN; Siqueira MM; Lima MC; Ramos FLP; Bragagnolo CM; Camacho LAB; Maia MLS
Mem Inst Oswaldo Cruz; 2019 Mar; 114():e180517. PubMed ID: 30843921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
